bretolap tablet - Lapatinib (250mg) medicine

bretolap tablet

4.3 (6 reviews)
๐Ÿญ Alkem Laboratories Ltd ๐Ÿ“ฆ Varies by brand ๐Ÿ’Š Allopathy ๐Ÿ“… Updated: Aug 22, 2026
โš ๏ธ Hepatotoxicity Risk ๐Ÿ“‹ Prescription Required ๐Ÿ’Š Generic Available
Medically Reviewed
SaathiMed Expert Panel | Aug 22, 2026

What is bretolap tablet used for?

Bretolap Tablet (Lapatinib) is used to treat ANTI NEOPLASTICS. It contains Lapatinib (250mg), which Reversible tyrosine kinase inhibitor that inhibits both epidermal growth factor . Always consult your doctor before use. Take as prescribed.

  • Generic Name: Lapatinib
  • Manufacturer: Alkem Laboratories Ltd
  • Form: Allopathy
  • Pregnancy Category: A
  • Prescription Required: Yes
๐Ÿ’ก Did You Know? India has the highest number of USFDA-compliant plants outside the USA.

๐Ÿ’Š bretolap tablet Uses & Benefits

Advanced or metastatic breast cancer with HER2 overexpression, in combination with capecitabine or letrozole.

Off-label uses: Non-small cell lung cancer, Head and neck cancer, Esophageal cancer

๐Ÿ“‹ Drug Information

Generic Name(s)Lapatinib
Brand NameBretolap Tablet
ManufacturerAlkem Laboratories Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassTyrosine kinase inhibitors
Route of AdministrationOral
StorageStore at 20-25ยฐC (68-77ยฐF); protect from moisture.
Shelf LifeAs per manufacturer

๐Ÿ”ฌ Pharmacology (PK/PD)

Pharmacokinetics

AbsorptionIncomplete and variable oral absorption; absorption is increased with food.
DistributionExtensively distributed into tissues; crosses the blood-brain barrier to a limited extent.
Protein Binding>99% bound to albumin and alpha-1 acid glycoprotein.
MetabolismExtensively metabolized in the liver, primarily by CYP3A4 and CYP3A5, with minor contribution from CYP2C8.
Half-LifeApproximately 24 hours (range 11-45 hours).
ExcretionPrimarily eliminated in feces (about 90%) as metabolites; less than 2% excreted unchanged in urine.
BioavailabilityNot well defined; oral bioavailability is variable and incomplete.
Onset of ActionNot well defined; therapeutic effects may take several weeks.
Peak Plasma TimeApproximately 4-6 hours after oral administration.
Duration of ActionNot well defined; sustained inhibition of EGFR and ErbB2 pathways.

How It Works

Reversible tyrosine kinase inhibitor that inhibits both epidermal growth factor receptor (EGFR/ErbB1) and human epidermal growth factor receptor 2 (ErbB2/HER2).

Mechanism Steps

1Lapatinib binds reversibly to the ATP-binding site of EGFR and HER2 tyrosine kinases.
2Inhibits autophosphorylation and downstream signaling pathways (MAPK, PI3K/Akt).
3Blocks cell cycle progression at G1/S phase.

๐Ÿ’ก How to Take bretolap tablet

Follow your doctor's prescription exactly.

โš ๏ธ Side Effects of bretolap tablet

โœ… Common Side Effects

  • Diarrhea
  • Nausea
  • Vomiting
  • Fatigue
  • Rash
  • Anorexia

๐Ÿšจ Serious Side Effects

  • Hepatotoxicity
  • Cardiotoxicity (LVEF decline)
  • QT prolongation
  • Interstitial lung disease
  • Severe diarrhea

โš ๏ธ Rare Side Effects

  • Stevens-Johnson syndrome
  • Angioedema
  • Pancreatitis
  • Pulmonary embolism

Consult your doctor if you experience any unusual symptoms.

๐Ÿ”ฌ Drug Interactions

โš ๏ธ DrugSeverityEffect
Ketoconazole Major Increased lapatinib exposure
Carbamazepine Major Decreased lapatinib exposure
Warfarin Moderate Increased INR

๐Ÿšจ Major Interactions

  • CYP3A4 inducers
  • CYP3A4 inhibitors
  • P-glycoprotein inhibitors
  • Grapefruit juice

โšก Moderate Interactions

  • Antacids
  • H2 receptor antagonists
  • Proton pump inhibitors

โ„น๏ธ Minor Interactions

  • Substrates of CYP3A4
  • Substrates of P-glycoprotein

๐Ÿฝ๏ธ Food Interactions

High-fat meals increase absorption; avoid grapefruit juice.

๐Ÿท Alcohol Interaction

No specific interaction reported; caution due to hepatotoxicity risk.

๐Ÿ›ก๏ธ Safety & Warnings

๐Ÿšซ Contraindications

Hypersensitivity to lapatinib, severe hepatic impairment, pregnancy.

๐Ÿ“Š Monitoring Parameters

Liver function tests, cardiac function (LVEF), ECG for QT interval, diarrhea, and skin reactions.

๐Ÿคฑ Lactation Safety

Not recommended; excreted in breast milk in animal studies.

๐Ÿ’Š Overdose Management

No specific antidote; symptomatic and supportive care; monitor for QT prolongation.

โฐ Missed Dose

If a dose is missed, take it as soon as remembered unless it is less than 12 hours until the next dose; do not double dose.

๐Ÿ‘จโ€โš•๏ธ Reviewed by Expert

SaathiMed Expert Panel

MD, PhD - Pharmacology

Last reviewed on: Aug 22, 2026

๐Ÿ”— View Profile

๐Ÿ”„ Substitutes for bretolap tablet

View All

Alternative brands with exact same active ingredient (Lapatinib (250mg)):

Medical Note: Always consult your doctor before switching medications.

โญ User Reviews

Happy Patient Jul 10, 2026

Helpful and effective medicine as per my experience. Always consult a doctor.

Trusted Reviewer Jul 10, 2026

This medicine was effective for me. I followed the doctor's advice.

Regular Customer Jul 10, 2026

Helpful and effective medicine as per my experience. Always consult a doctor.

Certified Buyer Jul 10, 2026

Effective and reliable. Worked as expected.

Certified Buyer Jul 10, 2026

Good quality medicine. Satisfied with the outcome.

๐Ÿ˜Š Was this information helpful?

Browse Medicines A-Z

Search our extensive medical database alphabetically.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory